mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0003 |
mRNA |
ciclopirox |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0003 |
mRNA |
NSC95397 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0004 |
mRNA |
Parthenolide |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0005 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0005 |
mRNA |
GW-405833 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0005 |
mRNA |
LY-2183240 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0006 |
mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0006 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0006 |
mRNA |
Cerulenin |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0007 |